134 related articles for article (PubMed ID: 29769598)
1. Germline mutation in the TP53 gene in uveal melanoma.
Hajkova N; Hojny J; Nemejcova K; Dundr P; Ulrych J; Jirsova K; Glezgova J; Ticha I
Sci Rep; 2018 May; 8(1):7618. PubMed ID: 29769598
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
[TBL] [Abstract][Full Text] [Related]
3. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
[TBL] [Abstract][Full Text] [Related]
4. Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer.
Boru G; Grosel TW; Pilarski R; Stautberg M; Massengill JB; Jeter J; Singh A; Marino MJ; McElroy JP; Davidorf FH; Cebulla CM; Abdel-Rahman MH
Genes Chromosomes Cancer; 2019 Sep; 58(9):650-656. PubMed ID: 30883995
[TBL] [Abstract][Full Text] [Related]
5. A population-based analysis of germline BAP1 mutations in melanoma.
O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ
Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663
[TBL] [Abstract][Full Text] [Related]
6. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients.
Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH
Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149
[TBL] [Abstract][Full Text] [Related]
7. Frequent mutation of BAP1 in metastasizing uveal melanomas.
Harbour JW; Onken MD; Roberson ED; Duan S; Cao L; Worley LA; Council ML; Matatall KA; Helms C; Bowcock AM
Science; 2010 Dec; 330(6009):1410-3. PubMed ID: 21051595
[TBL] [Abstract][Full Text] [Related]
8. Functional assay for assessment of pathogenicity of BAP1 variants.
Repo PE; Backlund MP; Kivelä TT; Turunen JA
Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
[TBL] [Abstract][Full Text] [Related]
10. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
Oncogene; 2021 Jan; 40(3):618-632. PubMed ID: 33208912
[TBL] [Abstract][Full Text] [Related]
11. TP53, MSH4, and LATS1 germline mutations in a family with clustering of nervous system tumors.
Kim YH; Ohta T; Oh JE; Le Calvez-Kelm F; McKay J; Voegele C; Durand G; Mittelbronn M; Kleihues P; Paulus W; Ohgaki H
Am J Pathol; 2014 Sep; 184(9):2374-81. PubMed ID: 25041856
[TBL] [Abstract][Full Text] [Related]
12. BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma.
Zhang C; Wu S
Mol Med; 2023 Sep; 29(1):126. PubMed ID: 37710185
[TBL] [Abstract][Full Text] [Related]
13. Connecting molecular pathways to hereditary cancer risk syndromes.
Testa JR; Malkin D; Schiffman JD
Am Soc Clin Oncol Educ Book; 2013; ():81-90. PubMed ID: 23714463
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of driver events in metastatic uveal melanoma.
Karlsson J; Nilsson LM; Mitra S; Alsén S; Shelke GV; Sah VR; Forsberg EMV; Stierner U; All-Eriksson C; Einarsdottir B; Jespersen H; Ny L; Lindnér P; Larsson E; Olofsson Bagge R; Nilsson JA
Nat Commun; 2020 Apr; 11(1):1894. PubMed ID: 32313009
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing of uveal melanoma with clinical and histological correlations: Prognostic value of new mutations in the PI3K/AKT/mTOR pathway.
Pérez-Pérez M; Agostino A; de Sola-Llamas CG; Ruvolo M; Vilches-Arenas A; Relimpio-López MI; Espejo-Arjona F; Macías-García L; De Miguel-Rodríguez M; García-Escudero A; Idoate MA; Ríos-Martín JJ
Clin Exp Ophthalmol; 2023 Nov; 51(8):822-834. PubMed ID: 37803816
[TBL] [Abstract][Full Text] [Related]
16. The Pediatric and Young Adult Choroidal and Ciliary Body Melanoma Genetic Study, A Survey by the European Ophthalmic Oncology Group.
van Poppelen NM; Cassoux N; Turunen JA; Naus NC; Verdijk RM; Vaarwater J; Cohen V; Papastefanou VP; Kiratli H; Saakyan SV; Tsygankov AY; Rospond-Kubiak I; Mudhar HS; Salvi SM; Kiilgaard JF; Heegaard S; Moulin AP; Saornil MA; Garciá-Alvarez C; Fili M; Eide NA; Meyer P; Kivelä TT; de Klein A; Kilic E; Al-Jamal RT
Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):12. PubMed ID: 38573618
[TBL] [Abstract][Full Text] [Related]
17. Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants.
Villy MC; Le Ven A; Le Mentec M; Masliah-Planchon J; Houy A; Bièche I; Vacher S; Vincent-Salomon A; Dubois d'Enghien C; Schwartz M; Piperno-Neumann S; Matet A; Malaise D; Bubien V; Lortholary A; Ait Omar A; Cavaillé M; Stoppa-Lyonnet D; Cassoux N; Stern MH; Rodrigues M; Golmard L; Colas C
J Natl Cancer Inst; 2024 Apr; 116(4):580-587. PubMed ID: 38060262
[TBL] [Abstract][Full Text] [Related]
18. Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.
Dalmasso B; Pastorino L; Nathan V; Shah NN; Palmer JM; Howlie M; Johansson PA; Freedman ND; Carter BD; Beane-Freeman L; Hicks B; Molven A; Helgadottir H; Sankar A; Tsao H; Stratigos AJ; Helsing P; Van Doorn R; Gruis NA; Visser M; Wadt KAW; Mann G; Holland EA; Nagore E; Potrony M; Puig S; Menin C; Peris K; Fargnoli MC; Calista D; Soufir N; Harland M; Bishop T; Kanetsky PA; Elder DE; Andreotti V; Vanni I; Bruno W; Höiom V; Tucker MA; Yang XR; Andresen PA; Adams DJ; Landi MT; Hayward NK; Goldstein AM; Ghiorzo P; ;
Genet Med; 2021 Nov; 23(11):2087-2095. PubMed ID: 34262154
[TBL] [Abstract][Full Text] [Related]
19. Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response.
Zhang P; Kitchen-Smith I; Xiong L; Stracquadanio G; Brown K; Richter PH; Wallace MD; Bond E; Sahgal N; Moore S; Nornes S; De Val S; Surakhy M; Sims D; Wang X; Bell DA; Zeron-Medina J; Jiang Y; Ryan AJ; Selfe JL; Shipley J; Kar S; Pharoah PD; Loveday C; Jansen R; Grochola LF; Palles C; Protheroe A; Millar V; Ebner DV; Pagadala M; Blagden SP; Maughan TS; Domingo E; Tomlinson I; Turnbull C; Carter H; Bond GL
Cancer Res; 2021 Apr; 81(7):1667-1680. PubMed ID: 33558336
[TBL] [Abstract][Full Text] [Related]
20. Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families.
Wang X; Deng L; Ping L; Shi Y; Wang H; Feng F; Leng X; Tang Y; Xie Y; Ying Z; Liu W; Zhu J; Song Y
Int J Cancer; 2024 Jul; 155(1):93-103. PubMed ID: 38446987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
